View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

DOJ/DEA RIN: 1117-AB42 Publication ID: Spring 2017 
Title: ●Implementation of the Comprehensive Addiction and Recovery Act of 2016 and the Department of Health and Human Services Regulations Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder 
Abstract:

On July 22, 2016, the Comprehensive Addiction and Recovery Act of 2016 became law. One section of the CARA amended the Controlled Substances Act to expand the categories of practitioners who may, under certain conditions on a temporary basis, dispense a narcotic drug in schedule III, IV, or V for the purpose of maintenance treatment or detoxification treatment. Separately, the Department of Health and Human Services, by final rule effective August 8, 2016, increased to 275 the maximum number of patients that a practitioner may treat for opioid use disorder without being separately registered under the CSA for that purpose. By this rulemaking, DEA is amending its regulations to incorporate these statutory and regulatory changes.

 

 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1301   
Legal Authority: 21 U.S.C. 823   
Legal Deadline:
Action Source Description Date
Final  Statutory    01/22/2018 
Timetable:
Action Date FR Cite
Final Action  09/00/2017 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Michael J. Lewis
Section Chief
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 598-6812
Fax:202 307-9536